Australia's most trusted
source of pharma news
Posted 25 January 2022 AM
If Bayer boss Ashraf Al-Ouf could make just one improvement to the Australian pharmaceutical industry it would be - not surprisingly - reforming the much critcised health technology assessment system.
His drive runs deep and stems from witnessing at a young age the positive impact medicines can have on patients, their families and the broader community.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.